Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and COVID-19: Demonstrating the Actionability of Real World Evidence.

Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers and COVID-19: Demonstrating the Actionability of Real World Evidence. Am J Hypertens. 2020 Nov 06;: Authors: Hennessy S, Cohen JB PMID: 33156920 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33156920?dopt=Abstract

Source: American Journal of Hypertension - November 6, 2020 Category: Cardiology Authors: Hennessy S, Cohen JB Tags: Am J Hypertens Source Type: research

More News: Cardiology | COVID-19 | Hypertension